# Gradual Withdrawal of Remifentanil Infusion Reduced Postoperative Pain and Opioid Requirement During Breast Surgery

> **NCT03756233** · NA · COMPLETED · sponsor: **Samsung Medical Center** · enrollment: 60 (actual)

## Conditions studied

- Pain, Postoperative

## Interventions

- **DRUG:** Remifentanil

## Key facts

- **NCT ID:** NCT03756233
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-26
- **Primary completion:** 2019-07-01
- **Final completion:** 2019-07-03
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2019-09-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03756233

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03756233, "Gradual Withdrawal of Remifentanil Infusion Reduced Postoperative Pain and Opioid Requirement During Breast Surgery". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03756233. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*